Thulium Fiber Laser (TFL) Versus MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors: A Randomized Controlled Clinical Study
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Over 18 years of age at the time of enrollment.
• Patients presented with visual criteria suggesting bladder tumor by outpatient cystoscopy will be legible for inclusion.
Locations
Other Locations
Canada
Thunder Bay Regional Health Sciences Centre
RECRUITING
Thunder Bay
Contact Information
Primary
Rabail Siddiqui
rabail.siddiqui@tbh.net
(807) 684-6000
Backup
Shalyn Littlefield
shalyn.littlefield@tbh.net
(807) 684-6000
Time Frame
Start Date: 2023-10-16
Estimated Completion Date: 2026-10
Participants
Target number of participants: 100
Treatments
Active_comparator: Thulium Fibre Laser
Participants randomized to this arm will undergo bladder resection using the TFL laser
Active_comparator: MOSES Holmonium
Participants randomized to this arm will undergo bladder resection using the MOSES holmium laser.
Related Therapeutic Areas
Sponsors
Leads: Thunder Bay Regional Health Research Institute